Gelonghui on October 30th: wuhan easy diagnosis biomedicine (002932.SZ) announced the third quarter report for 2024, with the company's revenue of 0.226 billion yuan in the first three quarters, a year-on-year decrease of 63.95%; net income attributable to shareholders of the listed company was 80.9384 million yuan, a year-on-year decrease of 44.30%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was -39.0766 million yuan; basic earnings per share was 0.35 yuan.
明德生物(002932.SZ)：前三季度净利润8093.84万元 同比下降44.30%
Wuhan Easy Diagnosis Biomedicine (002932.SZ): net income for the first three quarters was 80.9384 million yuan, a year-on-year decrease of 44.30%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated